Mirum Pharmaceuticals (MIRM) P/B ratio

P/B ratio today
14.7×

Mirum Pharmaceuticals (MIRM) trades at 14.7× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 12.6×. That is 44.7% higher than the 8.7× of fiscal 2024. Figures as of 18 Nov 2026, 09:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
14.7×
P/B ratio, fiscal 2025
12.6×
Change on fiscal 2024
+44.7%
Highest on record
12.6×fiscal 2025
Lowest on record
4.0×fiscal 2021
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Mirum Pharmaceuticals P/B ratio, in more detail

Today's figure is 16.4% above the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2021–2025), the highest was 12.6× in fiscal 2025 and the lowest 4.0× in fiscal 2021. Today's P/B ratio is above every one of the 5 fiscal year-ends on record; their median is 4.9×.

History · 5 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Mirum Pharmaceuticals P/B ratio, year by year

Mirum Pharmaceuticals (MIRM) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today14.7×—$91.95—
202512.6× 44.7% up$78.99$6.27
20248.7× 79.4% up$41.35$4.75
20234.9× 4.0% up$29.52$6.08
20224.7× 16.0% up$19.50$4.18
20214.0×—$15.95$3.96
2020——$17.46—
2019——$24.52—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on MIRM

Mirum Pharmaceuticals, figure by figure

Mirum Pharmaceuticals (MIRM) overview: price, valuation and scorecardAll health care companies by market value

Mirum Pharmaceuticals P/B ratio: questions and answers

What is Mirum Pharmaceuticals's P/B ratio?

Mirum Pharmaceuticals (MIRM) trades at 14.7× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 12.6×. That is 44.7% higher than the 8.7× of fiscal 2024.

Is Mirum Pharmaceuticals's P/B ratio high or low compared with its own history?

Today's P/B ratio is above every one of the 5 fiscal year-ends on record; their median is 4.9×.

What are the highest and lowest P/B ratio figures on record for Mirum Pharmaceuticals?

Across the 5 fiscal year-ends on record (2021–2025), the highest was 12.6× in fiscal 2025 and the lowest 4.0× in fiscal 2021.

How is Mirum Pharmaceuticals's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Mirum Pharmaceuticals it is on record here for 5 fiscal years, 2021 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Mirum Pharmaceuticals (MIRM) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MIRM/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.